US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 12.765
  • -0.165-1.28%
Trading May 10 14:19 ET
270.36MMarket Cap-2042P/E (TTM)

Enanta Pharmaceuticals Key Stats

Enanta Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

May 6, 2024

Revenue(YoY)

17.05M

-4.16%
EPS(YoY)

-1.47

+17.88%

Strong Buy

May 9, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 17.285M--
Aug 5, 20242024/Q3-- / 17.464M--
May 6, 20242024/Q217.054M / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--
Nov 20, 20232023/Q418.932M / 17.498M--
Aug 7, 20232023/Q318.892M / 16.736M--
May 8, 20232023/Q217.795M / 19.058M--
Feb 7, 20232023/Q123.585M / 22.478M--
Nov 21, 20222022/Q420.317M / 23.132M--
Aug 8, 20222022/Q319.479M / 20.734M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 17.285M--
Aug 5, 20242024/Q3-- / 17.464M--
May 6, 20242024/Q217.054M / 16.207M--
Feb 7, 20242024/Q118.003M / 21.946M--
Nov 20, 20232023/Q418.932M / 17.498M--
Aug 7, 20232023/Q318.892M / 16.736M--
May 8, 20232023/Q217.795M / 19.058M--
Feb 7, 20232023/Q123.585M / 22.478M--
Nov 21, 20222022/Q420.317M / 23.132M--
Aug 8, 20222022/Q319.479M / 20.734M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 9, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg